CN101066335B - Chinese medicine for treating thromboangiitis obliterans and phlebitis and its preparation method - Google Patents
Chinese medicine for treating thromboangiitis obliterans and phlebitis and its preparation method Download PDFInfo
- Publication number
- CN101066335B CN101066335B CN2007100157987A CN200710015798A CN101066335B CN 101066335 B CN101066335 B CN 101066335B CN 2007100157987 A CN2007100157987 A CN 2007100157987A CN 200710015798 A CN200710015798 A CN 200710015798A CN 101066335 B CN101066335 B CN 101066335B
- Authority
- CN
- China
- Prior art keywords
- phlebitis
- parts
- thromboangiitis obliterans
- treatment
- chinese patent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 208000001297 phlebitis Diseases 0.000 title claims abstract description 22
- 208000033386 Buerger disease Diseases 0.000 title claims description 20
- 206010043540 Thromboangiitis obliterans Diseases 0.000 title claims description 20
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 239000002994 raw material Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 8
- 241000283956 Manis Species 0.000 claims description 8
- 241000237636 Pheretima Species 0.000 claims description 8
- 241000522620 Scorpio Species 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 241000272074 Bungarus Species 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000009490 scorpio Substances 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000293861 Scrophularia nodosa Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 230000036407 pain Effects 0.000 description 15
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 241000545442 Radix Species 0.000 description 4
- 241000405217 Viola <butterfly> Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 201000005060 thrombophlebitis Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000003156 vasculitic effect Effects 0.000 description 2
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- SRWKSFRBHIWJSD-UHFFFAOYSA-N 6-cyclohexylhexan-1-ol Chemical compound OCCCCCCC1CCCCC1 SRWKSFRBHIWJSD-UHFFFAOYSA-N 0.000 description 1
- 241000271039 Agkistrodon Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001128140 Reseda Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 206010068887 Tobacco poisoning Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000021156 intermittent vascular claudication Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 201000002818 limb ischemia Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003752 saphenous vein Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000002465 tibial artery Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to Chinese medicine technology, and is especially one kind of Chinese medicine for treating throboangiitis obliterans and phlebitis and its preparation process. The Chinese medicine is prepared with figwort root, peach kernel, pangolin scale, earthworm, red sage and other seven kinds of Chinese medicinal materials in certain weight proportion, and through soaking in spirit, decocting and bottling. It has high effective rate and curative rate of treating throboangiitis obliterans and phlebitis and its preparation process.
Description
One, technical field
The present invention relates to a kind of treatment thromboangiitis obliterans, phlebitis Chinese patent medicine and preparation method thereof, belong to treatment vasculitis, phlebitis Chinese patent drug technique field.
Two, background technology
At present, treatment thromboangiitis obliterans, phlebitis adopt operative treatment, wound are arranged, to bring painful big of patient and therapeutic effect is undesirable; The employing Drug therapy, also not effective especially at present medicine.
Three, summary of the invention
The object of the present invention is to provide a kind ofly can overcome the defective that prior art exists, and effective percentage reaches more than 90%, treatment thromboangiitis obliterans more than 45% of cure rate, phlebitis Chinese patent medicine and preparation method thereof.
The present invention is based on motherland's medical science to thromboangiitis obliterans and thrombophlebitis pathogeny, become just to execute and control and further to the modern pharmacology exploratory development, it is closely related etc. to think that the vital organs of the human body and extremity nine orifices have.Finally cause function to get muddled, QI-blood circulation is lacked of proper care and is fallen ill.Thromboangiitis obliterans (venation blood stasis symptom) belongs to the traditional Chinese medical science " gangrene of finger or toe " category.Because feelings will internal injury, caused by liver and kidney deficiency and experiencing due to tobacco poisoning, the wound etc., sick at the extremity blood vessels, but substantial connection arranged with Liver and kidney two is dirty.Thrombophlebitis belongs to Chinese medicine categories such as " superficial obstructive phlebitis diseases ", and its cause of disease is the damp and hot evil poison of diseases caused by exogenous pathogenic factor, and feelings will is hindered etc.With damp invasion of lower energizer, qi depression to blood stasis is main pathogenesis to disease at blood vessels.Chinese patent medicine heat-clearing and toxic substances removing of the present invention, blood circulation promoting and dispersing pathogen accumulation, dispelling wind and removing obstruction in the collateral, compensate qi and blood, blood viscosity lowering, vessel softening, increase elasticity are set up the circulation of side limb and are the Therapeutic Principle.Eliminate to suffer from limb ischemia, blood stasis, swelling, pain and fester, sign symptom and reach and cure vasculitic effect.
A kind of treatment thromboangiitis obliterans of the present invention, phlebitis Chinese patent medicine include wine, water and raw material, and according to weight proportion, raw material comprises following component:
Radix Scrophulariae 10-20 part, Semen Persicae 10-16 part, Squama Manis 4-8 part, Pheretima 10-15 part, Radix Salviae Miltiorrhizae 18-25 part, Radix Angelicae Sinensis 10-20 part, Scorpio 2-6 part, Herba Violae 10-25 part, 2040 parts of Flos Lonicerae, Radix Astragali 40-60 part, Oletum Trogopterori 10-16 part, Bungarus Parvus 2-6 part, the weight proportion of wine, water, raw material are that 500-800 part wine is joined 300-600 part water, join 150-200 part raw material.
A large amount of Traditional Chinese medical theory and modern medicine studies prove that each composition pharmacological and formulation ratio thereof carry out a large amount of exploratory developments in the Chinese patent medicine of the present invention, and it is concluded active ingredient and acts on as follows:
Radix Scrophulariae: nature and flavor hardship, sweet, salty, cold, return the lung kidney channel, contain Radix Scrophulariae glycoside, alkaloid etc., the heat clearing away YIN nourishing, detoxicating and resolving stagnation of pathogens has inhibitory action to bacillus pyocyaneus.
Semen Persicae: nature and flavor hardship, sweet, flat, GUIXIN liver large intestine channel contains amygdalin, fatty wet goods, and removing blood stasis has significant anticoagulant effect.Cure mainly: stasis, wind illness, hectic fever due to YIN-deficiency, cold and heat, pain etc.
Radix Salviae Miltiorrhizae: the nature and flavor hardship, be slightly cold, the GUIXIN Liver Channel, contain TANSHINONES etc.The expansion peripheral vessels, anticoagulation, anti-platelet aggregation, conscience blood part has blood circulation promoting and blood stasis dispelling, cooling blood and relieving pain, clearing heat for detumescence etc.
Radix Angelicae Sinensis: nature and flavor are sweet, hot, warm, return liver heart spleen channel, contain volatile oil, alkaloid, have and invigorate blood circulation, enrich blood, and Fibrinogen is descended, and can enrich blood, effects such as cold expelling, pain relieving.
Pheretima: nature and flavor are salty, cold, return the Liver and kidney lung meridian, and property is apt to away scurry, current meridians, effects such as expelling cold and dampness.
Squama Manis: the big gun Squama Manis: nature and flavor are salty, and flavor is cold, returns liver stomach warp, interior logical internal organs, the effects such as meridians, detumescence and apocenosis of passing through inside.
Bungarus Parvus: nature and flavor are sweet, salty, warm, return Liver Channel, effects such as dispelling, collateral-activating.
Scorpio: nature and flavor suffering, flat, return Liver Channel, dehumidifying removes wind, detoxicating and resolving stagnation of pathogens, effects such as removing obstruction in the collateral to relieve pain, sore swollen toxin.
Flos Lonicerae: nature and flavor are sweet, cold, return lung, stomach, large intestine channel, contain cyclohexanhexanol, and the reseda flavin has the broad-spectrum antibacterial action.
The Radix Astragali: sweet, the tepor of nature and flavor, return spleen, lung meridian, contain saccharide, choline, antithrombotic effect is arranged, promoting pus discharge and tissue regeneration strengthening improves sanguimotor effect.
Herba Violae: nature and flavor hardship, suffering, cold, the GUIXIN Liver Channel, heat-clearing and toxic substances removing contains glycoside, flavonoid etc., and the broad-spectrum antibacterial action is arranged.
Oletum Trogopterori: nature and flavor are sweet, warm, return Liver Channel, go into liver blood part, promoting blood circulation and stopping pain, promoting blood circulation etc.
All medicines synthesize Synergistic treatment: with heat-clearing and toxic substances removing, and blood circulation promoting and blood stasis dispelling, anti-inflammation detumescence improves hemorheology, and promoting tissue regeneration and ulcer healing is cured vasculitic purpose thereby reach.
A kind of manufacture method for the treatment of thromboangiitis obliterans, phlebitis Chinese patent medicine of the present invention may further comprise the steps:
At first, get each component mix homogeneously according to weight proportion;
Then, soaked 30-60 minute with drinks;
Carried out fried back sub-bottling fried 40-80 minute.
Instructions of taking: every day three times is for oral administration, obeys 30 milliliters at every turn, and every day 3 times, one month is a course of treatment, the shortest 2 courses of treatment, the longest 6 courses of treatment, average 3 courses of treatment, can effectively treat thromboangiitis obliterans, phlebitis.
A kind of treatment thromboangiitis obliterans of the present invention, phlebitis Chinese patent medicine, promoting blood circulation to remove obstruction in the collateral, heat-clearing and toxic substances removing, damp eliminating, cold setting about, the side is with medicines such as Semen Persicae, Radix Salviae Miltiorrhizae, gathers promoting blood circulation to restore menstrual flow, removing obstruction for relieving pain altogether.Cold-damp pathogenic heat poison adds Flos Lonicerae, Herba Violae, heat-clearing and toxic substances removing, detumescence, evacuation of pus etc.Agkistrodon, Scorpio expel wind to dredge collateral, eliminating stagnation disappear bitterly.Oletum Trogopterori eliminating stasis to stop pain, clearing heat for calming endogenous wind, current meridians are selected Pheretima etc. for use.QI and blood deficiency, so with the Radix Astragali, Radix Angelicae Sinensis, and Radix Angelicae Sinensis, the Radix Astragali are invigorated blood circulation, hemopoietic, pain relieving, and QI and blood must be logical, not eliminating evil just the wound, and treating both the principal and secondary aspects of a disease, cold and heat decompose, all card cancellations.A kind of treatment thromboangiitis obliterans of the present invention, phlebitis Chinese patent medicine, effective percentage is more than 90%, and obvious effective rate is more than 75%, and cure rate is more than 45%.
Four, the specific embodiment
Describe the present invention in detail with embodiment below, but these embodiment must not be interpreted as the limitation of the present invention that goes up in all senses.
Embodiment 1
A kind of treatment thromboangiitis obliterans, phlebitis Chinese patent medicine, according to weight proportion, raw material comprises following component: 10 parts of Radix Scrophulariae, 10 parts in Semen Persicae, 4 parts of Squama Manis, 10 parts of Pheretimas, 18 parts of Radix Salviae Miltiorrhizaes, 10 parts of Radix Angelicae Sinensis, 2 parts of Scorpios, 10 parts of Herba Violaes, 20 parts of Flos Lonicerae, 40 parts of the Radixs Astragali, 10 parts of Oletum Trogopteroris, 2 parts of Bungarus Parvus, the weight proportion of wine, water, raw material are that 500 portions of wine are joined 300 parts of water, join 150 parts of raw materials.
Manufacture method may further comprise the steps: at first, get each component mix homogeneously according to weight proportion; Then, soaked 30-60 minute with drinks; Carried out fried back sub-bottling fried 40-80 minute.
Embodiment 2
Present embodiment 2 is with the difference of embodiment 1
A kind of treatment thromboangiitis obliterans, phlebitis Chinese patent medicine, according to weight proportion, raw material comprises following component: 20 parts of Radix Scrophulariae, 16 parts in Semen Persicae, 8 parts of Squama Manis, 15 parts of Pheretimas, 25 parts of Radix Salviae Miltiorrhizaes, 20 parts of Radix Angelicae Sinensis, 6 parts of Scorpios, 25 parts of Herba Violaes, 40 parts of Flos Lonicerae, 60 parts of the Radixs Astragali, 16 parts of Oletum Trogopteroris, 6 parts of Bungarus Parvus, the weight proportion of wine, water, raw material are that 800 portions of wine are joined 600 parts of water, join 200 parts of raw materials.
Embodiment 3
Present embodiment 3 is with the difference of embodiment 1
A kind of treatment thromboangiitis obliterans, phlebitis Chinese patent medicine, according to weight proportion, raw material comprises following component: 15 parts of Radix Scrophulariae, 13 parts in Semen Persicae, 6 parts of Squama Manis, 12 parts of Pheretimas, 21 parts of Radix Salviae Miltiorrhizaes, 15 parts of Radix Angelicae Sinensis, 4 parts of Scorpios, 17 parts of Herba Violaes, 30 parts of Flos Lonicerae, 50 parts of the Radixs Astragali, 13 parts of Oletum Trogopteroris, 4 parts of Bungarus Parvus, the weight proportion of wine, water, raw material are that 650 portions of wine are joined 450 parts of water, join 160 parts of raw materials.
Embodiment 4
Present embodiment 4 is with the difference of embodiment 1
A kind of treatment thromboangiitis obliterans, phlebitis Chinese patent medicine, according to weight proportion, raw material comprises following component: 10 parts of Radix Scrophulariae, 18 parts in Semen Persicae, 7 parts of Squama Manis, 15 parts of Pheretimas, 20 parts of Radix Salviae Miltiorrhizaes, 10 parts of Radix Angelicae Sinensis, 6 parts of Scorpios, 20 parts of Herba Violaes, 32 parts of Flos Lonicerae, 53 parts of the Radixs Astragali, 13 parts of Oletum Trogopteroris, 3 parts of Bungarus Parvus, the weight proportion of wine, water, raw material are that 800 portions of wine are joined 350 parts of water, join 180 parts of raw materials.
For showing the curative effect of Chinese patent medicine of the present invention, carried out clinical comparison.According to statistics, test group is totally 200 many cases, wherein male 137 examples, women 67 examples, the age between 23-76,46 years old mean age, medical history 2 months-3 years.Therapeutic Method is the fried Chinese medicine of wine of taking invention, and each 30 milliliters, every day 3 times, one month is a course of treatment, the shortest 2 courses of treatment, the longest 6 courses of treatment, average 3 courses of treatment.
The formulation criterion of therapeutical effect is as follows:
Recovery from illness: transference cure, turning out cloudy property of position test, it is normal that dorsal artery of foot recovers, and the phlebitis lower limb swell and ache and also recover fully, recover former work, follow up a case by regular visits to 2-3 and do not have recurrence.
Produce effects: clinical symptoms obviously alleviates, and intermittent claudication disappears, and suffer from limb color of the leather temperature and be clearly better, lower limb disappearances of swelling and ache, instep, posterior tibial artery fluctuate and are clearly better, and can be engaged in general work.
Take a turn for the better: pain relief, lower limb swell and ache and are clearly better, but ask night and still have rest pain, but can fall asleep, and the dorsal artery of foot pollex slightly takes a turn for the better.
Invalid: symptom and sign does not have improvement and takes a turn for the better.
Table 1: test group 1 curative effect situation
| Standard curative effect number | Invalid | Take a turn for the better | Produce effects | Recovery from illness |
| Total number of persons | Number | ％ | Number | ％ | Number | ％ | Number | ％ |
| 200 | 7 | 3.5％ | 23 | 11.5％ | 60 | 30％ | 110 | 55％ |
Table 2: test group 2 curative effect situations
From above-mentioned clinical patient treatment contrast test, choose the therapeutic effect that 2 examples further show Chinese patent medicine of the present invention.
Case 1: Lan Haozheng, man, 49 years old, the accounting of Xin Zhuan town, Zhaoyuan City, Shandong Province supply and marketing cooperative, be diagnosed as thromboangiitis obliterans in Yantai hospital in April, 2003, and the smelting of being in hospital is treated, prepare to implement amputation, the inventor locates to seek medical advice in May, 2003, the atrophy of Ipsilateral Calf muscle, the instep is brown-black, the dorsal artery of foot disappearance of beating, 2 * 3 centimetres of ulcer of thumb are suppurated, pain is heavier, can not walk, night, the pain increased can not fall asleep, and takes Chinese patent medicine preparation of the present invention, in 40 milliliters, the evening 50 milliliters, pain obviously alleviates after 7 days, one the course of treatment wound surface grow scarlet granulation, 2 the pain complete obiterations course of treatment, all healings and fully recovering of 4 the ulcer course of treatment.
Case 2: Zhang Jisheng, the man, 62 years old, the worker of Yantai Port Office, sub-district, Zhifu District letter home, Yantai City, at the Yantai hospital diagnosis is thrombophlebitis, does not take a turn for the better left lower extremity III ~ C pitting edema through wheat harvesting period treatment, skin is purplish red, the red and swollen tenderness of great saphenous vein many places lump, difficulty in walking can not be worked, the aggravation of movable back, early 30 milliliters of oral medicine of the present invention every days, 30 milliliters of noons, 40 milliliters of evenings, swell and ache after three days and be clearly better, can walk, return to one's perfect health 2 courses of treatment, follows up a case by regular visits to so far not recurrence.
Claims (3)
1. treat thromboangiitis obliterans, phlebitis Chinese patent medicine for one kind, it is characterized in that:
According to weight proportion, raw material is by Radix Scrophulariae 10-20 part, Semen Persicae 10-16 part, Squama Manis 4-8 part, Pheretima 10-15 part, Radix Salviae Miltiorrhizae 18-25 part, Radix Angelicae Sinensis 10-20 part, Scorpio 2-6 part, Herba Violae 10-25 part, Flos Lonicerae 20-40 part, Radix Astragali 40-60 part, Oletum Trogopterori 10-16 part, Bungarus Parvus 2-6 part is formed, the weight proportion of wine, water, raw material is that 500-800 part wine is joined 300-600 part water, joins 150-200 part raw material.
2. according to the described a kind of manufacture method for the treatment of thromboangiitis obliterans, phlebitis Chinese patent medicine of claim 1, it is characterized in that may further comprise the steps:
At first, get each component mix homogeneously according to weight proportion;
Then, soak with drinks;
Carry out fried, fried back sub-bottling.
3. according to the described a kind of manufacture method for the treatment of thromboangiitis obliterans, phlebitis Chinese patent medicine of claim 2, it is characterized in that the drinks soak time is 30-60 minute, fried 40-80 minute.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100157987A CN101066335B (en) | 2007-06-01 | 2007-06-01 | Chinese medicine for treating thromboangiitis obliterans and phlebitis and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100157987A CN101066335B (en) | 2007-06-01 | 2007-06-01 | Chinese medicine for treating thromboangiitis obliterans and phlebitis and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101066335A CN101066335A (en) | 2007-11-07 |
| CN101066335B true CN101066335B (en) | 2011-11-30 |
Family
ID=38879116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007100157987A Active CN101066335B (en) | 2007-06-01 | 2007-06-01 | Chinese medicine for treating thromboangiitis obliterans and phlebitis and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101066335B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105709187A (en) * | 2016-01-29 | 2016-06-29 | 王延刚 | Traditional Chinese medicinal composition for treating extremity superficial thrombophlebitis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1679843A (en) * | 2005-01-27 | 2005-10-12 | 朱腾月 | Oral medicine for treating thromboangitis obliterans |
| CN101053632A (en) * | 2006-04-13 | 2007-10-17 | 吴希文 | Traditional Chinese medicine for treating thromboangitis obliterans |
-
2007
- 2007-06-01 CN CN2007100157987A patent/CN101066335B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1679843A (en) * | 2005-01-27 | 2005-10-12 | 朱腾月 | Oral medicine for treating thromboangitis obliterans |
| CN101053632A (en) * | 2006-04-13 | 2007-10-17 | 吴希文 | Traditional Chinese medicine for treating thromboangitis obliterans |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101066335A (en) | 2007-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091203A (en) | External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof | |
| CN103768567B (en) | A kind of black plaster and preparation method thereof | |
| CN101062377B (en) | Adhesive plaster for diminishing inflammation, expelling wind and cold | |
| CN107693767A (en) | A kind of external medicine composition, its preparation method and application for preventing and treating diabetes | |
| CN102178877A (en) | External preparation for treating eczema of scrotum and preparation method thereof | |
| CN1363389A (en) | Chinese medicine in form of instant particles for treating dermatopathy | |
| CN102716334B (en) | Chinese medicinal composition for dispelling the cold and removing stasis | |
| CN1211108C (en) | Chinese patent drug for treating thrombus obliterating angiitis | |
| CN103585319B (en) | A kind ofly treat Chinese medicine composition of flaccidity caused by deficiency of both the liver and kidney and preparation method thereof | |
| CN101066335B (en) | Chinese medicine for treating thromboangiitis obliterans and phlebitis and its preparation method | |
| CN105031013A (en) | Medicine for treating lumbar vertebrae bone hyperplasia and preparation method thereof | |
| CN104383479A (en) | Traditional Chinese medicine foot bath composition for treating varicosity and preparation method of traditional Chinese medicine foot bath composition | |
| CN103860676B (en) | A kind of Chinese medicine for external application for the treatment of lumbar muscle strain and preparation method thereof | |
| CN103585483B (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
| CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof | |
| CN104116976A (en) | Externally-applied traditional Chinese medicine for treating knee osteoarthritis | |
| CN100579547C (en) | Orally taken Chinese medicine composition for treating thromboangitis obliterans | |
| CN104524397A (en) | Traditional Chinese medicine composition for assisted rehabilitation of stroke and preparation method of composition | |
| CN104623057A (en) | Pharmaceutical composition for treating diabetic feet and application pf pharmaceutical composition | |
| CN110302323A (en) | A kind of invigorating the spleen dehumidifying foot-soaking liquid and preparation method thereof and application method | |
| CN104666799A (en) | Blood circulation activating and blood stasis removing medicinal liquor for soft tissue injury and preparation method of medicinal liqour | |
| CN104189697A (en) | Traditional Chinese medicine patch for treating infantile enuresis, and preparation method thereof | |
| CN103301234A (en) | Traditional Chinese medicine composition for treating wound healing and preparation method thereof | |
| CN104523942B (en) | One treats colpitic external preparation | |
| CN107837375A (en) | A kind of saussurea involucrata Wind-dispelling ointment and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |